Aldeyra Therapeutics ALDX
Last Price
52 Week Range
$1.14 - $7.20
Next Earnings Date
Feb 27 2026 (Estimate)
Next Earnings Date
Feb 27 2026 (Est.)
Last Price
ALDX Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Aldeyra Therapeutics, Inc. | 8-K | November 13, 2025 | |
Aldeyra Therapeutics, Inc. | 10-Q | November 5, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | October 28, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | August 19, 2025 | |
Aldeyra Therapeutics, Inc. | 10-Q | August 7, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | July 17, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | June 26, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | June 17, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | June 11, 2025 | |
Aldeyra Therapeutics, Inc. | 10-Q | May 14, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | May 6, 2025 | |
Aldeyra Therapeutics, Inc. | DEFA14A | April 25, 2025 | |
Aldeyra Therapeutics, Inc. | ARS | April 25, 2025 | |
Aldeyra Therapeutics, Inc. | DEF 14A | April 25, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | April 17, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | April 3, 2025 | |
Aldeyra Therapeutics, Inc. | 10-K | February 28, 2025 | |
Aldeyra Therapeutics, Inc. | 8-K | November 18, 2024 | |
Aldeyra Therapeutics, Inc. | 10-Q | November 7, 2024 | |
Aldeyra Therapeutics, Inc. | 8-K | October 3, 2024 | |
Aldeyra Therapeutics, Inc. | 8-K | October 2, 2024 | |
Aldeyra Therapeutics, Inc. | 8-K | September 3, 2024 | |
Aldeyra Therapeutics, Inc. | 8-K | August 8, 2024 | |
Aldeyra Therapeutics, Inc. | 10-Q | August 1, 2024 | |
Aldeyra Therapeutics, Inc. | 8-K | August 1, 2024 | |
Aldeyra Therapeutics, Inc. | 8-K | June 20, 2024 | |
Aldeyra Therapeutics, Inc. | 8-K | June 13, 2024 | |
Aldeyra Therapeutics, Inc. | 8-K | June 7, 2024 | |
Aldeyra Therapeutics, Inc. | 10-Q | May 2, 2024 | |
Aldeyra Therapeutics, Inc. | 8-K | April 25, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.